Stephan A. Mayer

Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage

Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage

Detection of electrographic seizures with continuous EEG monitoring in critically ill patients

Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage

Prediction of Symptomatic Vasospasmafter Subarachnoid Hemorrhage: The Modified Fisher Scale

Effect of Cisternal and Ventricular Blood on Risk of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage:

Refractory Status Epilepticus

Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1)

Treatment of Refractory Status Epilepticus with Pentobarbital, Propofol, or Midazolam: A Systematic Review

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

A management algorithm for patients with intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC)

Impact of medical complications on outcome after subarachnoid hemorrhage*